How Important is Gender in Leadership in Pharmacovigilance? Personal Reflections from the First Female President of the International Society of Pharmacovigilance Mira Harrison-Woolrych From the ISoP 09 September 2022 Pages: 1015 - 1018
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment Johannes M. M. BootsRogier A. M. Quax Benefit-Risk Assessment Open access 06 September 2022 Pages: 1019 - 1036
Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis Marijana PutnikovicZoe JordanMichael Ward Systematic Review Open access 10 August 2022 Pages: 1037 - 1048
Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey Charles KhouriAyoub LarabiJeremy Ward Original Research Article 16 August 2022 Pages: 1049 - 1056
Analytical Approaches to Reduce Selection Bias in As-Treated Analyses with Missing In-Hospital Drug Information Yeon-Hee BaekYunha NohJu-Young Shin Original Research Article 17 August 2022 Pages: 1057 - 1067
Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe Kelly PlueschkeRobert FlynnChantal Quinten Original Research Article Open access 24 August 2022 Pages: 1069 - 1081
Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis Monica van HoofKatherine ChinchillaFlorence van Hunsel Original Research Article 25 August 2022 Pages: 1083 - 1098
A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis Upinder KaurAnju K.LSankha Shubhra Chakrabarti Original Research Article 27 August 2022 Pages: 1099 - 1109
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy Abstracts 29 August 2022 Pages: 1111 - 1327